CAFs drive chemotherapy resistance, whereas stimulation of the traditional Wnt pathway induces EMT in PCa cells by increasing the secretion of WNT16B—a source of CAFs—via NF-κB signaling (Sun et al., 2012). Here, NFKB1 is linked to posterior cortical atrophy.